1. Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry 
Gary R. Lichtenstein, Brian G. Feagan, Russell D. Cohen, Bruce A. Salzberg, Robert H. Diamond, Donny M. Chen, Michelle L. Pritchard, William J. Sandborn 
Clinical Gastroenterology and Hepatology 
Volume 4, Issue 5, Pages (May 2006)
DOI: /j.cgh
Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions

2. Figure 1
Flow of participation in the TREAT Registry. Infiximab-treated patients are those patients who received infiximab within 12 weeks prior to enrollment, who were scheduled to receive infiximab within 30 days of enrollment, or who received infiximab at some other point in the registry.
Clinical Gastroenterology and Hepatology 2006 4, DOI: ( /j.cgh )
Copyright © 2006 American Gastroenterological Association Institute Terms and Conditions